- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-1-1-1-mer
- Ligands
- 5 x CLR: CHOLESTEROL(Non-covalent)
- 2 x PLM: PALMITIC ACID(Non-covalent)
- 1 x J40: [(2R)-1-[oxidanyl-[(2R,3R,5S,6R)-2,3,5,6-tetrakis(oxidanyl)-4-phosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-3-tetradecanoyloxy-propan-2-yl] (5E,8E)-hexadeca-5,8,11,14-tetraenoate(Non-covalent)
- 1 x EZX: 1-(4-fluorophenyl)-4-[(7R)-2,5,11-triazatetracyclo[7.6.1.0^2,7.0^12,16]hexadeca-1(15),9,12(16),13-tetraen-5-yl]butan-1-one(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chen, Z. et al., Flexible scaffold-based cheminformatics approach for polypharmacological drug design. Cell (2024)
- Release Date
- 2024-02-28
- Peptides
- Guanine nucleotide-binding protein G(i) subunit alpha-1: A
Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1: B
ScFv16: C
Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2: D
Soluble cytochrome b562,5-hydroxytryptamine receptor 1A: E - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
ED
GE
R - Membrane
-
We predict this structure to be a membrane protein.